4//SEC Filing
SAHAREK JOHN P. 4
Accession 0001493152-22-005270
CIK 0001360214other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:00 PM ET
Size
9.0 KB
Accession
0001493152-22-005270
Insider Transaction Report
Form 4
SAHAREK JOHN P.
CEO & President, ImprimisRx
Transactions
- Exercise/Conversion
Common Stock
2022-02-19+50,000→ 80,000 total - Exercise/Conversion
Restricted Stock Unit
2022-02-19−50,000→ 0 totalExercise: $0.00→ Common Stock (50,000 underlying) - Tax Payment
Common Stock
2022-02-19$7.87/sh−25,923$204,014→ 54,077 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.
Documents
Issuer
HARROW HEALTH, INC.
CIK 0001360214
Entity typeother
Related Parties
1- filerCIK 0001632091
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:00 PM ET
- Size
- 9.0 KB